stella
beta
Study to Evaluate the Effectiveness of Tafasitamab in Combination With Lenalidomide Followed by Tafasitamab Monotherapy in Relapsed or Refractory Diffuse Large B-cell Lymphoma Non-transplant Eligible Patients in Italy (PRO-MIND) — Stella
Home
/
DLBCL - Diffuse Large B Cell Lymphoma
/
View on ClinicalTrials.gov
Recruiting
Back to DLBCL - Diffuse Large B Cell Lymphoma trials
Trial locations
(1 site)
Italy
Incyte Biosciences Italy S.r.l, Milan